The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Kraposhina A.Yu.

Regional Clinical Hospital

Sobko E.A.

Krasnoyarsk State Medical University named after prof. V.F. Voyno-Yasenetsky;
Regional Clinical Hospital

Demko I.V.

Regional Clinical Hospital

Katser A.B.

Voyno-Yasenetsky Krasnoyarsk State Medical University of the Ministry of Health of Russia

Kazmerchuk O.V.

Voyno-Yasenetsky Krasnoyarsk State Medical University of the Ministry of Health of Russia

Abramov Yu.I.

Voyno-Yasenetsky Krasnoyarsk State Medical University of the Ministry of Health of Russia

Treatment adherence, quality of life and disease control in patients with bronchial asthma: parts of a whole

Authors:

Kraposhina A.Yu., Sobko E.A., Demko I.V., Katser A.B., Kazmerchuk O.V., Abramov Yu.I.

More about the authors

Journal: Russian Journal of Preventive Medicine. 2022;25(3): 98‑103

Read: 1801 times


To cite this article:

Kraposhina AYu, Sobko EA, Demko IV, Katser AB, Kazmerchuk OV, Abramov YuI. Treatment adherence, quality of life and disease control in patients with bronchial asthma: parts of a whole. Russian Journal of Preventive Medicine. 2022;25(3):98‑103. (In Russ.)
https://doi.org/10.17116/profmed20222503198

Recommended articles:
Effi­ciency of complex medi­cal reha­bilitation after pulmonary enda­rterectomy. Russian Journal of Cardiology and Cardiovascular Surgery. 2024;(6):629-636
Simu­ltaneous auto­plastic repair and diastasis recti correction for linea alba hernias. Russian Journal of Evidence-Based Gastroenterology. 2024;(4):34-39
Quality of life of patients with multiple scle­rosis in the Smolensk region. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12):36-40

References:

  1. Global Initiative for Asthma (GINA). Global Strategy for Asthma Management and Prevention. Members of GINA Committees. 2021. [Electronic resource]. Accessed December 24, 2021. https://ginasthma.org/wp-content/uploads/2021/05/GINA-Main-Report-2021-V2-WMS.pdf
  2. Burke H, Davis J, Evans S, Flower L, Tan A, Kurukulaaratchy RJ. A multidisciplinary team case management approach reduces the burden of frequent asthma admissions. ERJ Open Research. 2016;2(3):00039-2016. https://doi.org/10.1183/23120541.00039-2016
  3. Avdeev SN, Nenasheva NM, Zhudenkov KV, Petrakovskaya VA, Izyumova GV. Prevalence, morbidity, phenotypes and other characteristics of severe bronchial asthma in Russian Federation. Pulmonologiya. 2018;28(3):341-358. (In Russ.). https://doi.org/10.18093/0869-0189-2018-28-3-341-358
  4. Avdeev SN. ACQ questionnaire as a new tool for assessing control of asthma. Pulmonologiya. 2011;(2):93-99. (In Russ.).
  5. Schuler M, Faller H, Wittmann M, Schultz K. Asthma Control Test and Asthma Control Questionnaire: factorial validity, reliability and correspondence in assessing status and change in asthma control. The Journal of Asthma. 2016;53(4):438-445.  https://doi.org/10.3109/02770903.2015.1101134
  6. Thomas M, Kay S, Pike J, Williams A, Rosenzweig JR, Hillyer EV, Price D. The Asthma Control Test (ACT) as a predictor of GINA guideline-defined asthma control: analysis of a multinational cross-sectional survey. Primary Care Respiratory Journal. 2009;18(1):41-49.  https://doi.org/10.4104/pcrj.2009.00010
  7. Menzies-Gow A, Chiu G. Perceptions of asthma control in the United Kingdom: a cross-sectional study comparing patient and healthcare professionals’ perceptions of asthma control with validated ACT scores. NPJ Primary Care Respiratory Medicine. 2017;27(1):48.  https://doi.org/10.1038/s41533-017-0050-x
  8. Matsunaga K, Hamada K, Oishi K, Yamaji Y, Hirano T. Factors associated with physician-patient discordance in the perception of asthma control. The Journal of Allergy and Clinical Immunology: In Practice. 2019;7(8):2634-2641. https://doi.org/10.1016/j.jaip.2019.04.046
  9. Crespo-Lessmann A, Plaza V, González-Barcala F-J, Fernández-Sánchez T, Sastre J. Concordance of opinions between patients and physicians and their relationship with symptomatic control and future risk in patients with moderate-severe asthma. BMJ Open Respiratory Research. 2017;4(1):e000189. https://doi.org/10.1136/bmjresp-2017-000189
  10. Chikumoto A, Matsunaga K, Oishi K, Hamada K, Yamaji Y, Hirano T. What are key symptoms to be captured for preventing a physician’s underestimation of asthma control? The Journal of Allergy and Clinical Immunology: In Practice. 2021;9(1):564-566.  https://doi.org/10.1016/j.jaip.2020.07.053
  11. Anderson 3rd WC, Gondalia R, Hoch HE, Kaye L, Barrett M, Szefler SJ, Stempel DA. Assessing asthma control: Comparison of electronic-recorded short-acting beta-agonist rescue use and self-reported use utilizing the Asthma control test. The Journal of Asthma. 2021;58(2):271-275.  https://doi.org/10.1080/02770903.2019.1687715
  12. Morrison D, Wyke S, Agur K, Cameron EJ, Docking RI, Mackenzie AM, McConnachie A, Raghuvir V, Thomson NC, Mair FS. Digital asthma self-management interventions: a systematic review. Journal of Medical Internet Research. 2014;16(2):e51.  https://doi.org/10.2196/jmir.2814
  13. Khusial RJ, Honkoop PJ, van der Meer V, Snoeck-Stroband JB, Sont JK. Validation of online Asthma Control Questionnaire and Asthma Quality of Life Questionnaire. ERJ Open Research. 2020;6(1):00289-2019. https://doi.org/10.1183/23120541.00289-2019
  14. Nemanic T, Sarc I, Skrgat S, Flezar M, Cukjati I, Malovrh MM. Telemonitoring in Asthma Control: A Randomized Controlled Trial. The Journal of Asthma. 2019;56(7):782-790.  https://doi.org/10.1080/02770903.2018.1493599
  15. Lycett H, Wildman E, Raebel EM, Sherlock J-P, Kenny T, Chan AHY. Treatment perceptions in patients with asthma: Synthesis of factors influencing adherence. Respiratory Medicine. 2018;141:180-189.  https://doi.org/10.1016/j.rmed.2018.06.032
  16. Iuga AO, McGuire MJ. Adherence and health care costs. Risk Management and Healthcare Policy. 2014;7:35-44.  https://doi.org/10.2147/RMHP.S19801
  17. IMS Institute for Healthcare Informatics Avoidable Costs in US Health Care. 2013. Accessed December 24, 2021. https://offers.premierinc.com/rs/381-NBB-525/images/Avoidable_Costs_in%20_US_Healthcare-IHII_AvoidableCosts_2013%5B1%5D.pdf
  18. Engelkes M, Janssens HM, de Jongste JC, Sturkenboom MCJM, Verhamme KMC. European Respiratory Journal. 2015;45(2):396-407.  https://doi.org/10.1183/09031936.00075614
  19. Vrijens B, De Geest S, Hughes DA, Przemyslaw K, Demonceau J, Ruppar T, Dobbels F, Fargher E, Morrison V, Lewek P, Matyjaszczyk M, Mshelia C, Clyne W, Aronson JK, Urquhart J; ABC Project Team. A new taxonomy for describing and defining adherence to medications. British Journal of Clinical Pharmacology. 2012;73(5):691-705.  https://doi.org/10.1111/j.1365-2125.2012.04167.x
  20. Raebel MA, Schmittdiel J, Karter AJ, Konieczny JL, Steiner JF. Standardizing terminology and definitions of medication adherence and persistence in research employing electronic databases. Medical Care. 2013;51(8 suppl 3):11-21.  https://doi.org/10.1097/MLR.0b013e31829b1d2a
  21. Sabate E. Adherence to long-term therapies: Evidence for action [Internet]. Geneva: World Health Organisation; 2003. Accessed December 24, 2021. https://apps.who.int/iris/bitstream/handle/10665/42682/9241545992.pdf?sequence=1&isAllowed=y
  22. Vrijens B, Dima AL, Van Ganse E, van Boven JFM, Eakin MN, Foster JM, de Bruin M, Chisholm A, Price D. What We Mean When We Talk About Adherence in Respiratory Medicine. The Journal of Allergy and Clinical Immunology: In Practice. 2016;4(5):802-812.  https://doi.org/10.1016/j.jaip.2016.05.019
  23. Cheen MHH, Tan YZ, Oh LF, Wee HL, Thumboo J. Prevalence of and factors associated with primary medication non-adherence in chronic disease: A systematic review and meta-analysis. International Journal of Clinical Practice. 2019;73(6):e13350. https://doi.org/10.1111/ijcp.13350
  24. Kardas G, Panek M, Kuna P, Kardas P. Primary non-adherence to inhaled medications measured with e-prescription data from Poland. Clinical and Translational Allergy. 2020;10:39.  https://doi.org/10.1186/s13601-020-00346-7
  25. Lehmann A, Aslani P, Ahmed R, Celio J, Gauchet A, Bedouch P, Bugnon O, Allenet B, Schneider MP. Assessing medication adherence: options to consider. International Journal of Clinical Pharmacy. 2014;36(1):55-69.  https://doi.org/10.1007/s11096-013-9865-x
  26. Lukina IuV, Kutishenko NP, Martsevich SIu, Shepel RN, Drapkina OM. Methodological recommendations: «Adherence to drug therapy in patients with chronic non-communicable diseases. Addressing the problem in a number of clinical situations». Profilakticheskaya meditsina. 2020;23(3):2042-2060. (In Russ.). https://doi.org/10.17116/profmed20202303242
  27. Lukina YuV, Kutishenko NP, Martsevich SYu, Drapkina OM. Questionnaires and scores for assessing medication adherence — advantages and disadvantages of the diagnostic method in research and actual clinical practice. Kardiovaskulyarnaya terapiya i profilaktika. 2020;19(3):232-239. (In Russ.). https://doi.org/10.15829/1728-8800-2020-2562
  28. Müller S, Maywald U, Timmermann H, Unmüßig V, Welte R, Hardtstock F, Wilke T. Identifying the Causes Increasing the Risk of Non-Adherence in Adult Patients with Asthma: An Analysis Combining Patient Survey Data with German Claims Data. Drugs — Real World Outcomes. 2021;8(2):207-214.  https://doi.org/10.1007/s40801-021-00236-9
  29. Müller S, Gorasso V, Hardtstock F, Wilke T. PRS59 adaption of the Adherence Barriers Questionnaire (ABQ) for use in patients with chronic obstructive pulmonary disese (COPD). Value Health. 2019;22:882-883.  https://doi.org/10.1016/j.jval.2019.09.2548
  30. Foot H, La Caze A, Baker P, Cottrell N. Better understanding the influence and complexity of beliefs on medication adherence in asthma. Patient Education and Counseling. 2019;102(3):564-570.  https://doi.org/10.1016/j.pec.2018.10.010
  31. Kleinsinger F. The Unmet Challenge of Medication Nonadherence. The Permanente Journal. 2018;22:18-033.  https://doi.org/10.7812/TPP/18-033
  32. Evsina OV. The quality of life in medicine — an important indicator of patient health status (review). Lichnost’ v menyayushchemsya mire: zdorov’e, adaptaciya, razvitie. 2013;1(1):119-133. (In Russ.).
  33. Sobko EA, Demko IV, Soloveva IA, Kraposhina AYu, Chubarova SV, Ishchenko OP, Soloveva VA, Volkova LN, Shvedova AA. Clinical effectiveness of allergenspecific immunotherapy. Sibirskoe medicinskoe obozrenie. 2015; 1:84-90. (In Russ.).
  34. Foster JM, McDonald VM, Guo M, Reddel HK. I have lost in every facet of my life: the hidden burden of severe asthma. The European Respiratory Journal. 2017;50(3):1700765. https://doi.org/10.1183/13993003.00765-2017
  35. Majellano EC, Clark VL, Foster JM, Gibson PG, McDonald VM. It’s like being on a roller coaster: the burden of caring for people with severe asthma. ERJ Open Research. 2021;7(2):00812-2020. https://doi.org/10.1183/23120541.00812-2020
  36. Lomper K, Chudiak A, Uchmanowicz I, Rosińczuk J, Jankowska-Polanska B. Effects of depression and anxiety on asthma-related quality of life. Pneumonologia i Alergologia Polska. 2016;84(4):212-221.  https://doi.org/10.5603/PiAP.2016.0026
  37. Kannan JA, Bernstein DI, Bernstein CK, Ryan PH, Bernstein JA, Villareal MS, Smith AM, Lenz PH, Epstein TG. Significant predictors of poor quality of life in older asthmatics. Annals of Allergy, Asthma and Immunology. 2015;115(3):198-204.  https://doi.org/10.1016/j.anai.2015.06.021
  38. Perel’man NL, Kolosov VP. Long-term change in health-related quality of life in patients with asthma. Pulmonologya. 2018;28(6):708-714. (In Russ.). https://doi.org/10.18093/0869-0189-2018-28-6-708-714

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.